DRUG REGULATIONS OF BONE RESORPTION IN ALVEOLAR BONE AND ITS MECHANISM OF ACTION
牙槽骨骨吸收的药物法规及其作用机制
基本信息
- 批准号:05454499
- 负责人:
- 金额:$ 3.97万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The following research was performed in order to study the drug regulation of bone resorption occurred in alveolar bone and its mechanism of action. Gene expressions of bone matrix proteins in rats fed with a low calcium diet was studied using a in situ hybridization. In situ hybridization showed the high levels of collagen, osteopontin, osteocalcin and bone sialprotein was located in the osteoblast in rats fed with a low calcium diet compared with the control rats. This observation indicated that bone formation activity was elevated during the low calcium state. Sodium salicylate, a non-steroidal antiinflammatory drug, inhibited the differentiation and the recruitment of osteoclast-like cells in mouse bone marrow culture. This indicates a mechanism of its inhibitory action on bone resorption. Osteoclasts isolated from mouse bone marrow were stained with a fluorescent dyes for Golgi apparatus, ER,and lysosome and were observed with time under the confocal laser scanning microscopy. The changes in cytoplasmic organella were recorded in the living osteoclasts. The present results demonstrates the drug regulations of bone resorption occurred in alveolar bone and its mechanism of action. These research approaches could develop new drugs for preventing alveolar bone resorption in future.
本研究旨在探讨药物对牙槽骨骨吸收的调节作用及其作用机制。应用原位杂交技术研究了低钙饮食大鼠骨基质蛋白基因的表达。原位杂交结果显示,低钙饮食组大鼠成骨细胞中胶原、骨桥蛋白、骨钙素和骨唾液酸蛋白的表达均高于对照组。这一观察结果表明,在低钙状态下骨形成活性升高。水杨酸钠,一种非甾体类抗炎药,在小鼠骨髓培养中抑制破骨细胞样细胞的分化和募集。这表明其对骨吸收的抑制作用的机制。从小鼠骨髓中分离的破骨细胞用高尔基体、ER和溶酶体的荧光染料染色,并在共聚焦激光扫描显微镜下随时间观察。在活的破骨细胞中记录胞质细胞器的变化。本研究结果表明,药物对牙槽骨骨吸收的调节作用及其作用机制。这些研究方法为将来开发预防牙槽骨吸收的新药提供了可能。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Soekanto A: "The effect of sodium Salicylate on osteoclast-like cell formation and bone resorptron in a mouse boue marrow culture." Calcified Tissue International. 54. 290-295 (1994)
Soekanto A:“水杨酸钠对小鼠布埃骨髓培养物中破骨细胞样细胞形成和骨吸收管的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arai N: "Osteopontin mRNA expression during bone nesorption:an in situ hybridization study of induced ectopic bone in the rat." Bone and Mineral. 22. 129-145 (1993)
Arai N:“骨吸收过程中骨桥蛋白 mRNA 的表达:诱导大鼠异位骨的原位杂交研究。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
SOEKANTO A,OHYA K,OGURA H: "THE EFFECT OF SODIUM SALICYLATE ON OSTEOCLAST-LIKE CELL FORMATION AND BONE RESORPTION IN A MOUSE BONE MARROW CULTURE." CALCIFED TISSUE INTERNATIONAL. 54. 290-295 (1994)
SOEKANTO A、OHYA K、OGURA H:“水杨酸钠对小鼠骨髓培养中破骨细胞样细胞形成和骨吸收的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Soekanto A: "The effect of sodium salicylate on osteolast-like cell formation and bone resorption in a mouse bone culture." Calcified Tissue International. 54. 290-295 (1994)
Soekanto A:“水杨酸钠对小鼠骨培养物中成骨细胞样细胞形成和骨吸收的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohya K: "Rats fed with a low-calcium diet as an in vivo experimental model for bone resorption." In Pharmacological Approuch to the study of the formation and the resorption mechanism of Hard Tissue. 93-114 (1994)
Ohya K:“用低钙饮食喂养的大鼠作为骨吸收的体内实验模型。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHYA Keiichi其他文献
OHYA Keiichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHYA Keiichi', 18)}}的其他基金
New bone resrption inhibitor based on agonistic function for TNF type 2 receptor
基于TNF 2型受体激动功能的新型骨再生抑制剂
- 批准号:
25670787 - 财政年份:2013
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of TNF-receptor Antagonists which have both Anti-inflammatory Action and Bone Formation Activity and Apply Them for the Treatment of Periodontal Diseases.
具有抗炎作用和骨形成活性的TNF受体拮抗剂的开发及其用于牙周病的治疗。
- 批准号:
24390413 - 财政年份:2012
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new therapeutic drugs for inflammatory bone destruction by the CIAM compound, a new TNF receptor antagonist.
通过 CIAM 化合物(一种新型 TNF 受体拮抗剂)开发治疗炎症性骨破坏的新治疗药物。
- 批准号:
19390471 - 财政年份:2007
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of New Hybrid-type Drugs Targeted to the Mechanism of Bone Remodeling
针对骨重塑机制的新型混合型药物的开发
- 批准号:
16209053 - 财政年份:2004
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Search for the new target points of bisphosphonates in bone cells: Their inhibitory actions on bone resorption and the stimulatory actions on bone formation
寻找双膦酸盐在骨细胞中的新靶点:其对骨吸收的抑制作用和对骨形成的刺激作用
- 批准号:
13470391 - 财政年份:2001
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of bone resorption in jaw by the drug administration. Analysis by the 3D-bone histomorphometry and by the measurement of bone mineral density.
通过药物管理调节颌骨吸收。
- 批准号:
11557134 - 财政年份:1999
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DEVELOPMENT OF DRUG WHICH REGULATES BONE RESORPTION ACTIVITY IN OSTEOCLASTS VIA CYTOSKELTON AND SIGNAL TRANSDUCTION SYSTEM
通过细胞骨架和信号传导系统调节破骨细胞骨吸收活性的药物的开发
- 批准号:
09470400 - 财政年份:1997
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A STUDY OF THE NEW INHIBITORY DRUG FOR BONE RESORPTION, BISPHOSPHONATES, ON THE ALVEOLAR BONE RESORPTION PROCESS.
新型骨吸收抑制药物双磷酸盐对牙槽骨吸收过程的研究。
- 批准号:
03670863 - 财政年份:1991
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
- 批准号:81601942
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidation of the mechanism of tooth eruption in DAP12 deficient and DAP12/FcRr deficient mice with impaired osteoclast differentiation using comprehensive gene expression analysis
使用综合基因表达分析阐明破骨细胞分化受损的 DAP12 缺陷和 DAP12/FcRr 缺陷小鼠的牙齿萌出机制
- 批准号:
15K11002 - 财政年份:2015
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CSF-1 Gene Expression in Osteoclast Biology
破骨细胞生物学中的 CSF-1 基因表达
- 批准号:
8631392 - 财政年份:2013
- 资助金额:
$ 3.97万 - 项目类别:
CSF-1 Gene Expression in Osteoclast Biology
破骨细胞生物学中的 CSF-1 基因表达
- 批准号:
8741919 - 财政年份:2013
- 资助金额:
$ 3.97万 - 项目类别:
CSF-1 Gene Expression in Osteoclast Biology
破骨细胞生物学中的 CSF-1 基因表达
- 批准号:
8885628 - 财政年份:2013
- 资助金额:
$ 3.97万 - 项目类别:
Analysis of Regulatory Mechanism of RANK Gene Expression in Osteoclast Precursor Cells
破骨细胞前体细胞RANK基因表达调控机制分析
- 批准号:
24590461 - 财政年份:2012
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression
AML1 在破骨细胞生成和破骨细胞基因表达中的作用
- 批准号:
8054585 - 财政年份:2010
- 资助金额:
$ 3.97万 - 项目类别:
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression
AML1 在破骨细胞生成和破骨细胞基因表达中的作用
- 批准号:
8247620 - 财政年份:2009
- 资助金额:
$ 3.97万 - 项目类别:
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression
AML1 在破骨细胞生成和破骨细胞基因表达中的作用
- 批准号:
7653035 - 财政年份:2009
- 资助金额:
$ 3.97万 - 项目类别:
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression
AML1 在破骨细胞生成和破骨细胞基因表达中的作用
- 批准号:
7924070 - 财政年份:2009
- 资助金额:
$ 3.97万 - 项目类别:
MI: MODULATING OSTEOCLAST GENE EXPRESSION AND FUNCTION
MI:调节破骨细胞基因表达和功能
- 批准号:
7870973 - 财政年份:2009
- 资助金额:
$ 3.97万 - 项目类别: